English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907464      Online Users : 960
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    圖書 [1/1]
    會議論文/會議摘要 [16/27]

    Collection Statistics

    近3年內發表的文件:23(34.85%)
    含全文筆數:65(98.48%)

    文件下載次數統計
    下載大於0次:65(100.00%)
    下載大於100次:63(96.92%)
    檔案下載總次數:20541(77.98%)

    最後更新時間: 2024-12-01 10:17


    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 26-50 of 66. (3 Page(s) Totally)
    << < 1 2 3 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2021-07-23 AUY922 induces retinal toxicity through attenuating TRPM1 Journal of Biomedical Science. 2021 Jul 23;28:Article number 55.
    2021-07-15 No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol Scientific Reports. 2021 Jul 15;11:Article number 14567.
    2021-06-12 Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers Oncoimmunology. 2021 Jun 12;10(1):Article number 1943253.
    2021-06-07 In vivo assessment of hypoxia levels in pancreatic tumors using a dual-modality ultrasound/photoacoustic imaging system Micromachines. 2021 Jun 7;12(6):Article number 668.
    2021-05-14 Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma PLoS ONE. 2021 May 14;16(5):Article number e0251811.
    2021-04 Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors Oncologist. 2021 Apr;26(4):e567-e579.
    2021-03-01 Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors Scientific Reports. 2021 Mar 1;11:Article number 4834.
    2021-01-13 Development of possible next line of systemic therapies for gemcitabine-resistant biliary tract cancers: A perspective from clinical trials Biomolecules. 2021 Jan 13;11(1):Article number 97.
    2020-12-29 Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan PLoS ONE. 2020 Dec 29;15(12):Article number e0244487.
    2020-11-13 The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.] Scientific Reports. 2020 Nov 13;10:Article number 20199.
    2020-11-01 Aptamer probed isolation of circulating tumor cells in cholangiocarcinoma patients Sensors and Actuators B: Chemical. 2020 Nov 1;322:Article number 128569.
    2020-10 Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study Liver International. 2020 Oct;40(10):2535-2543.
    2020-09-22 Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy Radiation Oncology. 2020 Sep 22;15:Article number 221.
    2020-08 Radiation dose escalation can improve local disease control and survival among esophageal cancer patients with large primary tumor volume receiving definitive chemoradiotherapy PLoS ONE. 2020 Aug;15(8):Article number e0237114.
    2020-05-26 Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan Journal of Biomedical Science. 2020 May 26;27:Article number 69.
    2020-05-04 The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort Scientific Reports. 2020 May 4;10:Article number 7420.
    2020-05 Impact of immune checkpoint inhibitors with or without a combination of tyrosine kinase inhibitors on organ-specific efficacy and macrovascular invasion in advanced hepatocellular carcinoma Oncology Research and Treatment. 2020 May;43(5):211-220.
    2020-05 Exploring Circulating Tumor Cells in cholangiocarcinoma using a novel glycosaminoglycan probe on a microfluidic platform Advanced Healthcare Materials. 2020 May;9(10):Article number 1901875.
    2020-02-27 Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer Radiation Oncology. 2020 Feb 27;15:Article number 48.
    2020-01 Review of preclinical and clinical studies of using cell-based therapy for secondary lymphedema Journal of Surgical Oncology. 2020 Jan;121(1):109-120.
    2020-01 A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study European Journal of Cancer. 2020 Jan;124:123-130.
    2019-10-05 Percutaneous computed tomography-guided coaxial core biopsy for the diagnosis of pancreatic tumors Journal of Clinical Medicine. 2019 Oct 5;8(10):Article number 1633.
    2019-06-10 Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma BMC Cancer. 2019 Jun 10;19:Article number 560.
    2017-09 Screening of peptide specific to cholangiocarcinoma cancer cells using an integrated microfluidic system and phage display technology Microfluidics and Nanofluidics. 2017 Sep;21(9):Article number 145.
    2017-07-01 Automated selection of aptamers against cholangiocarcinoma cells on an integrated microfluidic platform Biomicrofluidics. 2017 Jul 1;11(4):Article number 044101.

    Showing items 26-50 of 66. (3 Page(s) Totally)
    << < 1 2 3 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback